Evaluation of lipid profile measurements obtained from the Cholestech L.D.X analyzer.

BACKGROUND: The Cholestech L.D.X analyzer has the capability of performing a lipid profile in approximately 5 minutes. The purpose of this study was to determine analytical performance capability of the L.D.X to perform lipid profile measurements. METHODS: Forty subjects gave two finger capillary samples and one venous serum which were analyzed in duplicate by two technicians, on two different L.D.X analyzers. A local pathology laboratory was used as the standard for accuracy comparisons. Two controls with known values were provided by the manufacturer to assess within-day precision. Day-to-day precision was determined by analyzing high (240 mg/dL-1 total cholesterol (TC) and 60 mg/dL-1 high-density lipoprotein [HDL]) and low (200 mg/dL-1 TC and 35 mg/dL-1 HDL) human serum samples on 10 different days. RESULTS: Analysis of variance procedures revealed no significant differences between the two technicians or the two analyzers, nor among the fingerstick, venous serum, or reference measures for any of the analytes. The total error of measurement of TC, triglycerides, and HDL measurements were 6.3 to 16.2%, 14.8 to 30.8%, and 11.5 to 26.8%, respectively. In comparison to the National Cholesterol Education Program (NCEP) desirable, borderline-high, and high classifications obtained from the reference laboratory the L.D.X TC results were correctly classified in 92.5% of the cases. L.D.X triglyceride classifications of desirable, borderline hypertyglyceridemia, and distinct hypertriglyceridemia matched 100% with the classifications obtained from the reference laboratory. CONCLUSIONS: Although the Cholestech L.D.X analyzer did not consistently meet NCEP standards for acceptable total measurement error of TC, HDL, and triglyceride analyses, it seems capable of providing reasonable lipid profile measures in both a screening setting and a clinician office where the goal is correct classification of patients' results.

The bloodless lactate profile.

The blood lactate profile (HLa-P) is an accepted method of evaluating athletes and providing a basis for the prescription of training intensity. For both logistic and public health reasons HLa-P is less than optimal. In this study we evaluate the relative velocity or the %HR-max, obtained during a training session, as alternatives to HLa-P. Competitive speed skaters (N = 20) performed HLa-P consisting of 5.2000 m/400 m at incremental velocities ranging from very slow to maximal (time = 3.0-5.0 min). Blood lactate measured during a 60-s interval following each repetition was used to construct HLa-P and to predict the velocity associated with steady state (HLa = 4.0-6.5 mmol.l-1). Relative velocity was calculated relative to the velocity of the maximal trial. A plot of relative velocity and %HRmax vs HLa demonstrated that HLa = 4.0-6.5 mmol.l-1 occurred at a relative velocity of 78-88% (R2 = 0.807) and at 84-92 %HRmax (R2 = 0.748). In a separate training session the relative velocity and %HRmax models were cross validated by having the subjects skate 9.2000 m/400 m at constant velocity. HLa changes during the training session defined the presence/absence of steady state (delta HLa < 1.0 mM from trial 3 to 9). Comparing the velocity during the training session vs the velocity predicted from HLa-P, relative velocity model and %HRmax model allowed a test of the accuracy of bloodless means of defining steady state. HLa-P correctly predicted 81% of training session HLa responses, the relative velocity model correctly predicted 78%, and the %HRmax model correctly predicted 68%.(ABSTRACT TRUNCATED AT 250 WORDS)